MedPath

Improving self-esteem in traumatized youth: a transdiagnostic ecological momentary intervention trial (SELFIE)

Completed
Conditions
transdiagnostic study population, i.e., all youth exposed to childhood trauma)
mental health problems
childhood adversity
Registration Number
NL-OMON52597
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
174
Inclusion Criteria

1. Aged between 12 and 26 years
2. Score on questionnaires:
* RSES <26
* CTQ of:
- Emotional abuse * 13
- Physical abuse * 10
- Sexual abuse * 8
- Physical neglect * 10
- Emotional neglect * 15
* and/or RBQ score of:
- Reported being bullied sometimes, frequently or constantly and/or
- Classified the experience as *quite serious* or *extremely serious
* and/or CECA (parental conflict) score of:
- Frequency score of regularly or often and/or
- Severity score of *serious* or *violent
3. Willingness to participate in the SELFIE intervention
4. Ability to give written informed consent (parental consent in case of <16
years)

Exclusion Criteria

1. Insufficient command of Dutch so that the self-esteem EMI cannot be followed
and outcomes cannot be reasonably assessed in Dutch
2. Psychiatric symptoms due to an organic cause

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcomes will be the level of self-esteem as measured with Ecological<br /><br>Momentary Assessment using the PsyMate® App, the Rosenberg Self-Esteem Scale,<br /><br>and semi-structured interviews.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes will be implicit self-esteem, positive and negative<br /><br>schematic beliefs of self, resilience, self-compassion, emotional well-being,<br /><br>general psychopathology, functioning, and quality of life. Given that exposure<br /><br>to trauma and response to treatment may be reflected at the biological level in<br /><br>distinct epigenetic signatures, levels of DNA methylation in NR3C1 (i.e.<br /><br>glucocorticoid receptor 1 gene) and SLCA4 (i.e. the serotonin transporter gene)<br /><br>will be measured using targeted sequencing.</p><br>
© Copyright 2025. All Rights Reserved by MedPath